Coordinator, Emerging Therapeutics Strategy Program
Jennifer Day, PharmD is Coordinator of the Emerging Therapeutics Strategy Program which is part of Drug Intelligence and Strategy for Kaiser Permanente National Pharmacy. Dr. Day’s areas of expertise include drug information and analysis of clinical trial evidence, development of evidence-based guidelines, strategic planning for the use of biologics and emerging pharmaceuticals, including gene therapies and biosimilars, and pharmaceutical pipeline forecasting. She plays a key role in facilitating the development of innovative treatment pathways through collaboration with physicians and pharmacists in the various Kaiser Permanente regions to proactively evaluate and prepare for optimal use of new and pipeline emerging therapeutics.
Tuesday, October 20, 2020
3:00pm – 4:00pm